Breaking News, Collaborations & Alliances

ATMI, Artelis Form Disposable Biomanufacturing Pact

ATMI LifeSciences and Artelis have announced agreements to focus on the commercialization and distribution of Artelis’ proprietary disposable mixing technology integrated with ATMI’s proprietary film technology, and to jointly develop, test and manufacture single-use bioreactors/fermentors.

The agreements will leverage ATMI LifeSciences’ expertise in advanced ultra-clean film manufacturing and single-use mixing technology with Artelis’ knowledge of the cell culture process, fermentation applications and disposable bioreactors to provide customers with higher performance in purity, precision and process efficiency in the manufacture of advanced biopharmaceuticals.

ATMI LifeSciences Managing Director, Mario Philips, said: “Our initial focus has been to establish our scalable contained powder and liquid single-use mixing technologies. Now, through our alliance with Artelis we are completing our single-use mixing product offering for scalable liquid-to-liquid mixing applications. Artelis’ mixing technology is more advanced than the recirculation pump and magnetic mixer liquid-to-liquid mixing systems currently available in the marketplace. This enables us to have suitable mixing product offerings across all bioprocess applications for our customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters